Ivermectin and doxycycline treatments against onchocerciasis: adaptations and impact among semi-nomadic population in Massangam health district, Cameroon


Community knowledge, satellite imagery, semi-nomadic sensitisation and outreach strategies were employed to deliver ivermectin and doxycycline treatments against onchocerciasis in a semi-nomadic population. Doxycycline was offered only when skin snip examination revealed infection.

We found that about 50% of the population has either left or joined the community within eight months; 59% of people not born in the area arrived during the last five years; 28% of those older than nine years reported never taking ivermectin; 72% (compared to 51% previously) of eligible population (≥5 years) took ivermectin; and 47% participated in skin snip test. A high proportion of participants– 15% were infected. All the infected individuals (20) were treated, and no infection was found in almost all those retested (9/10).

This study highlights a high rate of onchocerciasis and the challenges of offering continuous treatment for a prolonged period (>10 years) to a mobile population. It further demonstrates that combining ivermectin and doxycycline is preferable in a mobile population as it is curative and can be given only once.

Visit the research study page for more information.

Relevant links

Visit the study page
Publication details
Date published
12 July 2023
Original research